MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Prodromal non-motor symptoms in Multiple System Atrophy. Differences between cerebellar and parkinsonian phenotypes.

P. Millar Vernetti, H. Kaufmann, JA. Palma (New York, USA)

Meeting: 2022 International Congress

Abstract Number: 1094

Keywords: Autonomic dysfunction, Multiple system atrophy(MSA): Clinical features

Category: Parkinsonism, Atypical: MSA

Objective: To determine the onset and prevalence of prodromal non-motor symptoms in patients with multiple system atrophy (MSA), both parkinsonian (MSA-P) and cerebellar (MSA-C) forms.

Background: Cardiovascular and urinary autonomic dysfunction, and REM sleep behavior disorder are well described prodromal manifestations of MSA. However, their prevalence and time of onset relative to the onset of motor abnormalities (MA) is not well defined.

Method: We performed a retrospective review of patients evaluated at the NYU Dysautonomia Center with a diagnosis of possible or probable MSA over the last 3 years, including information on age at onset of orthostatic intolerance (OI), lower urinary tract symptoms (LUTS), probable RBD,  (pRBD) and motor abnormalities (MA). Chi-square tests were used for qualitative variables. Mann-Whitney U test was used to compare quantitative variables. Measures of dispersion are expressed as “mean ± standard deviation” or “median (p25 to p75)”.

Results: A total of 91 patients with MSA (29 MSA-C, 62 MSA-P) were included (49 men, 54%). Age of onset of MA was 58±8 in MSA-C and 60±9 in MSA-P (p=0.321). pRBD was reported in 93% of MSA-C patients, with onset at age 53±9; and in 87% in MSA-P at age 54±11 in (p=0.38). OI was present in 66% of MSA-C with onset at age 55±9; and in 95% of MSA-P at age 59±9 (p<0.001). LUTS were present in 100% of MSA-C, with onset at age 58±8, and in 100% of MSA-P with onset at age 59±10 (p=0.684). pRBD before MA was reported by 76% of MSA-C with an interval of 3 (1-5) years; and in 50% of MSA-P with an interval of 5 (2-7) years (p=0.491); OI before MA was reported by 14% of MSA-C with an interval of 2 (1-3) years , and by 24% of MSA-P, with an interval of 2 (1-5) years in (p=0.18); LUTS before MA was reported by 38% of MSA-C with an interval of 2 (1-3) years , and by 53% of MSA-P with an interval of 2 (1-4) years (p=0.035).

Conclusion: Prodromal symptoms of cardiovascular or urinary autonomic dysfunction occur in in ~50% of patients with MSA. Autonomic symptoms precede motor abnormalities by up to 5 years. While there was no difference in prevalence or onset of OI or pRBD between MSA-P and MSA-C, LUTS were more significantly more frequent in the prodromal stage in MSA-P.

To cite this abstract in AMA style:

P. Millar Vernetti, H. Kaufmann, JA. Palma. Prodromal non-motor symptoms in Multiple System Atrophy. Differences between cerebellar and parkinsonian phenotypes. [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/prodromal-non-motor-symptoms-in-multiple-system-atrophy-differences-between-cerebellar-and-parkinsonian-phenotypes/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/prodromal-non-motor-symptoms-in-multiple-system-atrophy-differences-between-cerebellar-and-parkinsonian-phenotypes/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley